The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole...

The U.S. Food and Drug Administration (FDA) on Thursday approved Merck’s PREVYMIS™ (letermovir) once-daily tablets for oral use and injection for intravenous infusion. PREVYMIS is indicated for...

Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus...

A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit...

Researchers from the Liverpool School of Tropical Medicine (LSTM) Cochrane Infectious Diseases Group published two systematic reviews this week about the safety of mefloquine (Lariam) for preventing malaria...

Outpatient antibiotic use is a primary risk factor for acquiring Clostridium difficile infection in the community, reinforcing the need for appropriate prescribing in this setting, a new study published...

Picture a brand-new, unsharpened pencil. The graphite at its core can’t be used for writing until a pencil sharpener chews away its wooden tip. Now picture microcin B17, an antibiotic that kills...

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics. The genes...

The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services,...

A collaboration years in the making between The College of Idaho and Boise State University in the research of the microscopic parasite Giardia has resulted in a three-year, $418,000 grant from the National...